9D

Duearity ABFRA Duearity Stock Report

Last reporting period 30 Sep, 2023

Updated 30 Sep, 2024

Last price

Market cap $B

0

Micro

Exchange

XFRA - Deutsche Boerse AG

9DS.F Stock Analysis

9D

Uncovered

Duearity AB is uncovered by Eyestock quantitative analysis.

Market cap $B

0

Dividend yield

Shares outstanding

9.757 B

Duearity AB engages in the development and trade of prepackaged software. The company is headquartered in Malmo, Skane. The company went IPO on 2021-05-11. The firm's product is Tinearity G1. Tinearity G1 is a medical device that helps with tinnitus treatment. Tinearity G1 is based on Tinnitus Retraining Therapy, a white noise treatment that has been used clinically for several decades. Tinearity G1 consists of sound elements that lead white noise to the inner ear via the skull bone. The method is non-invasive and the ear canal is not affected.

View Section: Eyestock Rating